908 Devices PE Ratio 2020-2025 | MASS
Current and historical p/e ratio for 908 Devices (MASS) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. 908 Devices PE ratio as of June 17, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| 908 Devices PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-17 | 7.35 | 0.00 | |
| 2025-03-31 | 4.48 | $-0.54 | 0.00 |
| 2024-12-31 | 2.20 | $-2.10 | 0.00 |
| 2024-09-30 | 3.47 | $-1.77 | 0.00 |
| 2024-06-30 | 5.15 | $-1.15 | 0.00 |
| 2024-03-31 | 7.55 | $-1.07 | 0.00 |
| 2023-12-31 | 11.22 | $-1.13 | 0.00 |
| 2023-09-30 | 6.66 | $-1.21 | 0.00 |
| 2023-06-30 | 6.86 | $-1.19 | 0.00 |
| 2023-03-31 | 8.60 | $-1.16 | 0.00 |
| 2022-12-31 | 7.62 | $-1.07 | 0.00 |
| 2022-09-30 | 16.45 | $-0.88 | 0.00 |
| 2022-06-30 | 20.59 | $-0.87 | 0.00 |
| 2022-03-31 | 19.01 | $-0.88 | 0.00 |
| 2021-12-31 | 25.87 | $-0.80 | 0.00 |
| 2021-09-30 | 32.52 | $-2.16 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.262B | $0.060B |
| 908 Devices Inc. is a purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis. It conducts research, designs and manufactures products of mass spectrometry, microfluidic separations, software automation and machine learning. 908 Devices Inc. is headquartered in Boston. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.575B | 81.48 |
| Thermo Fisher Scientific (TMO) | United States | $152.039B | 18.50 |
| Edwards Lifesciences (EW) | United States | $44.083B | 28.78 |
| Alcon (ALC) | Switzerland | $42.518B | 28.73 |
| IDEXX Laboratories (IDXX) | United States | $42.037B | 48.87 |
| DexCom (DXCM) | United States | $32.149B | 50.30 |
| IQVIA Holdings (IQV) | United States | $27.142B | 15.43 |
| Mettler-Toledo (MTD) | United States | $24.013B | 29.24 |
| STERIS (STE) | Ireland | $23.741B | 26.13 |
| Waters (WAT) | United States | $20.370B | 29.20 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.723B | 0.00 |
| Hologic (HOLX) | United States | $14.429B | 15.78 |
| Sysmex ADR (SSMXY) | Japan | $10.852B | 30.58 |
| Penumbra (PEN) | United States | $9.933B | 79.32 |
| Masimo (MASI) | United States | $8.740B | 32.51 |
| Globus Medical (GMED) | United States | $7.974B | 18.99 |
| Glaukos (GKOS) | United States | $5.577B | 0.00 |
| Teleflex (TFX) | United States | $5.300B | 8.83 |
| TransMedics (TMDX) | United States | $4.833B | 104.38 |
| Integer Holdings (ITGR) | United States | $4.128B | 21.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.355B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.495B | 14.77 |
| Nihon Kohden (NHNKY) | Japan | $2.264B | 22.90 |
| Veracyte (VCYT) | United States | $2.071B | 29.27 |
| Elekta AB (EKTAY) | Sweden | $1.901B | 17.30 |
| Alphatec Holdings (ATEC) | United States | $1.617B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.383B | 0.00 |
| Artivion (AORT) | United States | $1.206B | 114.92 |
| Pulse Biosciences (PLSE) | United States | $1.061B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.945B | 5.12 |
| Beta Bionics (BBNX) | United States | $0.828B | 0.00 |
| SiBone (SIBN) | United States | $0.742B | 0.00 |
| IRadimed (IRMD) | United States | $0.740B | 37.75 |
| RxSight (RXST) | United States | $0.577B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.560B | 8.80 |
| Delcath Systems (DCTH) | United States | $0.534B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 12.29 |
| OrthoPediatrics (KIDS) | United States | $0.514B | 0.00 |
| AxoGen (AXGN) | United States | $0.444B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.433B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.431B | 0.00 |
| NeuroPace (NPCE) | United States | $0.363B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.357B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.330B | 9.06 |
| ClearPoint Neuro (CLPT) | United States | $0.323B | 0.00 |
| Neuronetics (STIM) | United States | $0.249B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.93 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.213B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.183B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.158B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.156B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.20 |
| EnVVeno Medical (NVNO) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.26 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |